Twist Bioscience Corp experienced a notable increase in stock price, driven by positive market sentiment and analyst upgrades.
Twist Bioscience Corp (NASDAQ:TWST) saw its stock price surge by 8.66% in yesterday's trading session, closing at CA$205.00. The company's recent developments in personalized mRNA cancer vaccines and advancements in AI-driven drug discovery have caught the attention of investors and analysts alike.
Advertisement
Twist Bioscience Corp
TWST.US
TWST.US
Twist Bioscience Corp
WealthAwesomeMarket cap
$13.59B
52W high
$207.90
52W low
$23.30
1W change
+14.14%
Beta
2.19
Analyst Price Targets
Based on analyst covering TWST · as of Oct 6, 2026
Wall Street analysts forecast TWST stock price to fall 38.9% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$125.17
-38.9% Upside
Previously C$120.83 on Oct 5, 2026
Current Price
C$205.00
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TWST's historical volatility
30-Day Vol
76.0%
Annualized
90-Day Vol
85.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$245.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$217.57 | C$167.36 – C$282.84 |
| 60 trading days | C$230.92 | C$159.34 – C$334.65 |
| 90 trading days | C$245.08 | C$155.58 – C$386.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of Twist Bioscience's advancements in AI and personalized medicine, as these factors may contribute to long-term growth and market positioning.
8.66%
Twist Bioscience's stock rose by 8.66% yesterday, reflecting strong investor interest and positive market sentiment.
Bull case
The recent momentum in Twist Bioscience's stock is backed by analyst upgrades, with several firms raising their price targets significantly. The company's focus on AI-driven drug discovery puts it in a strong position within a rapidly changing market.
Bear case
Even with the recent gains, some analysts are cautious, suggesting that the stock might already reflect much of the good news. Concerns about execution risks and competition in the market could create challenges in the near term.
Analyst Upgrades Boost Sentiment
Advertisement
Several analysts have recently raised their price targets for Twist Bioscience, indicating a bullish outlook for the company. For example, Guggenheim increased its target to US$212 from US$107, suggesting significant upside potential. This positive sentiment is evident in the stock's performance, as investors respond favorably to the news.
Advancements in AI-Driven Drug Discovery
Twist Bioscience's strategic focus on AI-driven drug discovery is positioning the company as a key player in the biotech sector. With projections indicating substantial growth in the AI drug discovery market, Twist's innovations could lead to increased revenue and market share, further driving investor interest.
Market Context and Future Outlook
While the recent surge in stock price is encouraging, investors should remain cautious. Some analysts warn that the stock may already reflect much of the anticipated growth, and execution risks remain a concern. As the company navigates the competitive landscape of biotech, its ability to deliver on promises will be crucial for sustaining investor confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
